ACETYLCYSTEINE injection United States - English - NLM (National Library of Medicine)

acetylcysteine injection

paddock laboratories, llc - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine injection is an antidote for acetaminophen overdose indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen. overdose incidences are divided into two types; acute ingestion or repeated supratherapeutic ingestion (rsi). [see dosage and administration (2) and acetaminophen assays – interpretation and methodology-(acute or repeated supratherapeutic ingestion) (1.1, 1.2) ]. on admission for suspected acute acetaminophen overdose, a serum blood sample should be drawn at least 4 hours after ingestion to determine the acetaminophen level and will serve as a basis for determining the need for treatment with acetylcysteine. if the patient presents after 4 hours post-ingestion, the serum acetaminophen sample should be determined immediately. acetylcysteine injection should be administered within 8 hours from acetaminophen ingestion for maximal protection against hepatic injury for patients whose serum acetaminophen levels fall above the “possib

ACETYLCYSTEINE SOLUTION Canada - English - Health Canada

acetylcysteine solution

sandoz canada incorporated - acetylcysteine - solution - 200mg - acetylcysteine 200mg - antidotes

ACETYLCYSTEINE SOLUTION USP Canada - English - Health Canada

acetylcysteine solution usp

hikma canada limited - acetylcysteine - solution - 200mg - acetylcysteine 200mg - antidotes

ACETYLCYSTEINE SOLUTION USP Canada - English - Health Canada

acetylcysteine solution usp

sterimax inc - acetylcysteine - solution - 200mg - acetylcysteine 200mg

ACETYLCYSTEINE injection, solution United States - English - NLM (National Library of Medicine)

acetylcysteine injection, solution

sagent pharmaceuticals - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine injection is indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion (rsi). acetylcysteine is contraindicated in patients with a previous hypersensitivity reaction to acetylcysteine [see warnings and precautions (5.1)] . risk summary limited published case reports and case series of pregnant women exposed to acetylcysteine during various trimesters are not sufficient to inform any drug associated risk. delaying treatment of acetaminophen overdose may increase the risk of maternal or fetal morbidity and mortality [see clinical considerations]. reproduction studies in rats and rabbits following oral administration of acetylcysteine during the period of organogenesis at doses similar to the total intravenous dose (based on the body surface area) did not cause any adverse effects to the fetus. the estimated background risk of major birth defects and miscarriage